$14.48
-0.08-0.55%
Last update: Dec 15, 3:04 PM
Comments
Loading...
Phathom Pharmaceuticals Stock Guidance | NASDAQ:PHAT | Benzinga
Phathom Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
FAQ
What is the most recent guidance for Phathom Pharmaceuticals (PHAT)?
There have been no specific sales or earnings guidance reported for Phathom Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
